BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
BioInvent International Price to Book Value : 6.600 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 6.600 |
| August 26, 2026 | 6.600 |
| August 25, 2026 | 6.600 |
| August 24, 2026 | 6.600 |
| August 21, 2026 | 6.600 |
| August 20, 2026 | 6.600 |
| August 19, 2026 | 6.600 |
| August 18, 2026 | 6.600 |
| August 17, 2026 | 6.600 |
| August 14, 2026 | 6.600 |
| August 13, 2026 | 6.600 |
| August 12, 2026 | 6.600 |
| August 11, 2026 | 6.600 |
| August 10, 2026 | 6.600 |
| August 07, 2026 | 6.600 |
| August 06, 2026 | 6.600 |
| August 05, 2026 | 6.600 |
| August 04, 2026 | 6.600 |
| August 03, 2026 | 6.600 |
| July 31, 2026 | 6.600 |
| July 30, 2026 | 6.600 |
| July 29, 2026 | 6.600 |
| July 28, 2026 | 6.600 |
| July 27, 2026 | 6.600 |
| July 24, 2026 | 6.600 |
| Date | Value |
|---|---|
| July 23, 2026 | 6.600 |
| July 22, 2026 | 6.600 |
| July 21, 2026 | 6.600 |
| July 20, 2026 | 6.600 |
| July 17, 2026 | 6.600 |
| July 16, 2026 | 6.600 |
| July 15, 2026 | 6.600 |
| July 14, 2026 | 6.600 |
| July 13, 2026 | 6.600 |
| July 10, 2026 | 6.600 |
| July 09, 2026 | 6.600 |
| July 08, 2026 | 6.600 |
| July 07, 2026 | 6.600 |
| July 06, 2026 | 6.600 |
| July 02, 2026 | 6.600 |
| July 01, 2026 | 6.600 |
| June 30, 2026 | 6.600 |
| June 29, 2026 | 4.695 |
| June 26, 2026 | 4.695 |
| June 25, 2026 | 4.695 |
| June 24, 2026 | 4.695 |
| June 23, 2026 | 4.695 |
| June 22, 2026 | 4.695 |
| June 18, 2026 | 4.695 |
| June 17, 2026 | 4.695 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BONESUPPORT HOLDING AB | 15.68 |
| Hansa Biopharma AB | -- |
| BioArctic AB | 14.29 |
| Swedish Orphan Biovitrum AB | 4.136 |
| Diamyd Medical AB | 4.027 |
Price to Book Value Related Metrics
| PS Ratio | 61.84 |
| PEG Ratio | -0.0424 |
| Price | 3.289 |
| Earnings Yield | -24.55% |
| Market Cap | 216.40M |
| PEGY Ratio | -0.0424 |